Balyasny Asset Management
LJPC

Balyasny Asset Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Balyasny Asset Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-34,269
Closed -$690K – 2005
2018
Q3 		$690K Buy
34,269
+22,951
+203% +$600K ﹤0.01% 1286
2018
Q2 		$330K Buy
+11,318
New +$349K ﹤0.01% 1486
2017
Q2 		– Sell
-15,100
Closed -$451K – 1981
2017
Q1 		$451K Buy
+15,100
New +$386K ﹤0.01% 1313
2016
Q2 		– Sell
-12,630
Closed -$264K – 1670
2016
Q1 		$264K Buy
+12,630
New +$225K ﹤0.01% 1036

Other funds holding LJPC

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management's LJPC Position: Q4 2018 in Review

Balyasny Asset Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2018, closing a stake of 34,269 shares — an estimated $690K sold.

Balyasny Asset Management first reported a position in LJPC in Q1 2016 and held it in 4 quarters. The position peaked at $690K in Q3 2018. 83 funds tracked by Wall St. Rank hold LJPC as of Q4 2018.

  • Balyasny Asset Management reported no remaining La Jolla Pharmaceutical Company position as of Q4 2018 after selling out during the quarter.
  • Balyasny Asset Management sold 34,269 La Jolla Pharmaceutical Company shares in Q4 2018, an estimated $690K.
  • Balyasny Asset Management first reported a position in La Jolla Pharmaceutical Company in Q1 2016 and held it in 4 quarters.
  • Balyasny Asset Management's La Jolla Pharmaceutical Company position peaked at $690K in Q3 2018.
  • 83 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2018.

Based on Balyasny Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.